Aeris Therapeutics  LLC, a Woburn-based drug developer focused on treatments for emphysema and other advanced lung diseases, has appointed a new chief financial officer in Charles R. Carter. In his new post, Carter will help bring the company’s AeriSeal System to global markets.
A 20-year life sciences and business veteran, Carter worked previously as CFO and head of business development for Cambridge rapid diagnostic test maker Intelligent Medical Devices Inc. He has also held financial management roles with Adnexus Therapeutics and Transkaryotic Therapies/Shire Pharmaceutical Group plc. He graduated from the University of Chicago with an MBA and master’s of science degree.